Villefontaine, France

Frederic Beseme

USPTO Granted Patents = 11 

Average Co-Inventor Count = 5.8

ph-index = 4

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 1998-2011

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Frederic Beseme: Innovator in Viral Research

Introduction

Frederic Beseme is a notable inventor based in Villefontaine, France. He has made significant contributions to the field of viral research, particularly in relation to multiple sclerosis and rheumatoid arthritis. With a total of 11 patents to his name, Beseme's work is recognized for its potential impact on diagnostic and therapeutic methods.

Latest Patents

Among his latest patents, Beseme has developed viral material and nucleotide fragments associated with multiple sclerosis for diagnostic, prophylactic, and therapeutic purposes. One of his inventions provides viral material in an isolated or purified state, which includes a genome comprising specific nucleotide sequences. These sequences are crucial for understanding the genetic components associated with multiple sclerosis. Another patent focuses on the use of viral material and nucleotide fragments for diagnosing and treating both multiple sclerosis and rheumatoid arthritis.

Career Highlights

Frederic Beseme is currently associated with bioMérieux, Inc., a company known for its expertise in diagnostics. His work at bioMérieux has allowed him to collaborate with other professionals in the field, enhancing the scope and impact of his research.

Collaborations

Some of his notable coworkers include Herve Perron and Frederic Bedin. Their collaborative efforts contribute to the advancement of research in viral diagnostics and therapeutics.

Conclusion

Frederic Beseme's innovative work in viral research and his numerous patents highlight his significant contributions to the medical field. His ongoing research continues to pave the way for advancements in the diagnosis and treatment of serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…